Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Financial Sense Advisors Inc.

Financial Sense Advisors Inc. grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 83.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 135,224 shares of the pharmacy operator’s stock after purchasing an additional 61,630 shares during the period. Walgreens Boots Alliance makes up approximately 1.0% of Financial Sense Advisors Inc.’s holdings, making the stock its 24th largest holding. Financial Sense Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $2,933,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Quadrant Capital Group LLC raised its stake in shares of Walgreens Boots Alliance by 33.8% in the 4th quarter. Quadrant Capital Group LLC now owns 7,494 shares of the pharmacy operator’s stock valued at $196,000 after acquiring an additional 1,893 shares during the period. Syon Capital LLC purchased a new position in Walgreens Boots Alliance in the fourth quarter valued at about $333,000. New York Life Investment Management LLC lifted its stake in shares of Walgreens Boots Alliance by 0.6% during the fourth quarter. New York Life Investment Management LLC now owns 115,196 shares of the pharmacy operator’s stock worth $3,008,000 after purchasing an additional 690 shares in the last quarter. EP Wealth Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at about $297,000. Finally, Corient Private Wealth LLC raised its holdings in shares of Walgreens Boots Alliance by 38.9% during the 4th quarter. Corient Private Wealth LLC now owns 280,545 shares of the pharmacy operator’s stock valued at $7,325,000 after buying an additional 78,523 shares during the period. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 4.1 %

Shares of NASDAQ WBA opened at $11.10 on Thursday. Walgreens Boots Alliance, Inc. has a twelve month low of $11.10 and a twelve month high of $31.32. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The business has a 50 day simple moving average of $16.23 and a 200-day simple moving average of $19.95.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. During the same quarter in the prior year, the firm earned $1.00 EPS. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. Analysts expect that Walgreens Boots Alliance, Inc. will post 2.87 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were given a dividend of $0.25 per share. The ex-dividend date was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a yield of 9.01%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

Insider Activity at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The stock was bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the transaction, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 17.40% of the company’s stock.

Analyst Upgrades and Downgrades

WBA has been the topic of a number of analyst reports. Truist Financial dropped their price objective on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a research note on Friday, June 28th. Evercore ISI dropped their target price on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a research report on Friday, June 28th. Barclays reduced their price target on Walgreens Boots Alliance from $21.00 to $19.00 and set an “underweight” rating for the company in a report on Monday, June 24th. Deutsche Bank Aktiengesellschaft dropped their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a report on Wednesday, April 3rd. Finally, Morgan Stanley dropped their price objective on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a report on Friday, June 28th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $17.71.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.